AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
185.58
-2.51 (-1.33%)
May 8, 2025, 4:00 PM - Market closed
AbbVie Market Cap
AbbVie has a market cap or net worth of $328.29 billion as of May 9, 2025. Its market cap has increased by 10.69% in one year.
Market Cap
328.29B
Enterprise Value
390.75B
1-Year Change
10.69%
Ranking
Category
Stock Price
$185.58
Market Cap Chart
Since January 2, 2013, AbbVie's market cap has increased from $55.49B to $328.29B, an increase of 491.62%. That is a compound annual growth rate of 15.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2025 | 332.05B | 5.74% |
| Dec 31, 2024 | 314.02B | 14.77% |
| Dec 29, 2023 | 273.61B | -4.27% |
| Dec 30, 2022 | 285.80B | 19.40% |
| Dec 31, 2021 | 239.37B | 26.54% |
| Dec 31, 2020 | 189.17B | 44.48% |
| Dec 31, 2019 | 130.93B | -5.58% |
| Dec 31, 2018 | 138.67B | -10.18% |
| Dec 29, 2017 | 154.39B | 51.71% |
| Dec 30, 2016 | 101.76B | 5.08% |
| Dec 31, 2015 | 96.84B | -7.12% |
| Dec 31, 2014 | 104.26B | 24.10% |
| Dec 31, 2013 | 84.01B | 51.40% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 667.69B |
| Johnson & Johnson | 375.47B |
| UnitedHealth Group | 353.53B |
| Novo Nordisk | 301.56B |
| Abbott Laboratories | 233.50B |
| Novartis AG | 218.96B |
| AstraZeneca | 217.30B |
| Merck & Co. | 195.48B |